No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours

Citation
S. Jefferies et al., No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours, BR J CANC, 85(9), 2001, pp. 1383-1386
Citations number
40
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
85
Issue
9
Year of publication
2001
Pages
1383 - 1386
Database
ISI
SICI code
0007-0920(20011102)85:9<1383:NGMIC(>2.0.ZU;2-Y
Abstract
There is increasing evidence that predisposition to some cancers has a gene tic component. There is a high incidence of loss of heterozygosity on chrom osome 9, in the region of tumour suppressor gene, CDKN2A (also known as p16 ), in sporadic squamous cell cancer of the head and neck (SCCHN). To invest igate the possibility that CDKN2A may be involved in the inherited suscepti bility to SCCHN, the 3 coding exons of CDKN2A were sequenced in 40 patients who had developed a second primary cancer after an index squamous cell can cer of the head and neck. No mutations were found and we conclude that CDKN 2A mutations do not play a major role in cancer susceptibility in this grou p. (C) 2001 Cancer Research Campaign.